Atlas Trials

Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis

Clinical trial NCT04160897 · UNKNOWN

Trial details

NCT number
NCT04160897
Sponsor
Qing XIe
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatitis B, ChronicHepatocellular CarcinomaCompensated Cirrhosis
Start date
2019-10-22
Primary completion
2020-10-31
Enrollment
4000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.